(19)
(11) EP 2 560 633 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
12.08.2020 Bulletin 2020/33

(45) Mention of the grant of the patent:
13.05.2020 Bulletin 2020/20

(21) Application number: 11772752.9

(22) Date of filing: 22.04.2011
(51) International Patent Classification (IPC): 
A61K 9/107(2006.01)
A61K 31/202(2006.01)
A61P 25/28(2006.01)
A61K 47/14(2017.01)
A61K 31/201(2006.01)
(86) International application number:
PCT/US2011/033542
(87) International publication number:
WO 2011/133841 (27.10.2011 Gazette 2011/43)

(54)

INTRAVENOUS OMEGA-3 FATTY ACID COMPOSITIONS & METHOD OF USE

INTRAVENÖSE OMEGA-3-FETTSÄUREN-ZUSAMMENSETZUNGEN SOWIE VERWENDUNGSVERFAHREN DAFÜR

COMPOSITIONS INTRAVEINEUSES D'ACIDES GRAS OMÉGA-3 ET MÉTHODE D'UTILISATION


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 23.04.2010 US 327252 P

(43) Date of publication of application:
27.02.2013 Bulletin 2013/09

(73) Proprietor: The Government of the United States, as represented by The Secretary of the Army
Fort Detrick, MD 21702-9223 (US)

(72) Inventor:
  • LEWIS, Michael
    Rockville, MD 20852 (US)

(74) Representative: Boult Wade Tennant LLP 
Salisbury Square House 8 Salisbury Square
London EC4Y 8AP
London EC4Y 8AP (GB)


(56) References cited: : 
EP-B1- 0 863 754
WO-A2-01/89474
WO-A2-2008/036353
CA-A1- 2 511 902
WO-A1-90/08544
WO-A2-2007/070307
WO-A2-2010/104575
US-A- 5 874 470
   
  • Y. A CARPENTIER ET AL: "Rapid cellular enrichment of eicosapentaenoate after a single intravenous injection of a novel medium-chain triacylglycerol:fish-oil emulsion in humans", AMERICAN JOURNAL OF CLINICAL NUTRITION, vol. 91, no. 4, 10 February 2010 (2010-02-10), pages 875-882, XP055092955, ISSN: 0002-9165, DOI: 10.3945/ajcn.2009.27951
  • CALDER P.C.: 'Long-chain n-3 fatty acids and inflammation: potential application in surgical and trauma patients.' BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH vol. 36, no. 4, 2003, pages 433 - 446, XP003018982
  • MICHAEL-TITUS A.T.: 'Omega-3 fatty acids acids and neurological injury' PROSTAGLANDINS, LEUKOTRIENES AND ESSENTIAL FATTY ACIDS vol. 77, no. 5-6, 2007, pages 295 - 300, XP022371997
  • WU A. ET AL.: 'Dietary Omega-3 Fatty Acids Normalize BDNF Levels, Reduce Oxidative Damage, and Counteract Learning Disability after Traumatic Brain Injury in Rats.' JOURNAL OF NEUROTRAUMA vol. 21, no. 10, 2004, pages 1457 - 1467, XP008151907
  • WU A. ET AL.: 'Omega-3 Fatty Acids Supplementation Restores Mechanisms that Maintain Brain Homeostasis in Traumatic Brain Injury.' JOURNAL OF NEUROTRAUMA vol. 24, no. 10, 2007, pages 1587 - 1595, XP055070337
  • Document from "Nordic naturals" provided by the applicant submitted on 26.02.2017: Distillation Fact from Fiction Fish Oil Manufacturing Clarified 8 pages- No publication date
  • MICHAEL-TITUS ET AL: "Omega-3 fatty acids and neurological injury", PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, CHURCHILL LIVINGSTONE, EDINBURGH, vol. 77, no. 5-6, 26 November 2007 (2007-11-26), pages 295-300, XP022371997, ISSN: 0952-3278, DOI: 10.1016/J.PLEFA.2007.10.021
  • KHALID Q ET AL: "The fatty acid composition of edible marine fish oils.", JOURNAL OF THE AMERICAN OIL CHEMISTS' SOCIETY APR 1968, vol. 45, no. 4, April 1968 (1968-04), pages 247-249, ISSN: 0003-021X
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).